These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12686370)

  • 1. CSF CRH in abstinent cocaine-dependent patients.
    Roy A; Bissette G; Williams R; Berman J; Gonzalez B
    Psychiatry Res; 2003 Mar; 117(3):277-80. PubMed ID: 12686370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.
    Brady KT; McRae AL; Moran-Santa Maria MM; DeSantis SM; Simpson AN; Waldrop AE; Back SE; Kreek MJ
    Arch Gen Psychiatry; 2009 Apr; 66(4):422-30. PubMed ID: 19349312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters.
    Brunner J; Stalla GK; Stalla J; Uhr M; Grabner A; Wetter TC; Bronisch T
    J Psychiatr Res; 2001; 35(1):1-9. PubMed ID: 11287050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
    Zhang GF; Ren YP; Sheng LX; Chi Y; Du WJ; Guo S; Jiang ZN; Xiao L; Luo XN; Tang YL; Smith AK; Liu ZQ; Zhang HX
    Am J Drug Alcohol Abuse; 2008; 34(6):760-8. PubMed ID: 19016181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
    Adinoff B; Anton R; Linnoila M; Guidotti A; Nemeroff CB; Bissette G
    Neuropsychopharmacology; 1996 Sep; 15(3):288-95. PubMed ID: 8873112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.
    Barr CS; Dvoskin RL; Yuan Q; Lipsky RH; Gupte M; Hu X; Zhou Z; Schwandt ML; Lindell SG; McKee M; Becker ML; Kling MA; Gold PW; Higley D; Heilig M; Suomi SJ; Goldman D
    Arch Gen Psychiatry; 2008 Aug; 65(8):934-44. PubMed ID: 18678798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.
    Mantsch JR; Taves S; Khan T; Katz ES; Sajan T; Tang LC; Cullinan WE; Ziegler DR
    Neurosci Lett; 2007 Mar; 415(3):269-73. PubMed ID: 17293045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary function during alcohol exposure and withdrawal and cocaine exposure.
    Wilkins JN; Gorelick DA; Nademanee K; Taylor A; Herzberg DS
    Recent Dev Alcohol; 1992; 10():57-71. PubMed ID: 1317048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone in depression and post-traumatic stress disorder.
    Kasckow JW; Baker D; Geracioti TD
    Peptides; 2001 May; 22(5):845-51. PubMed ID: 11337099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticotropin-releasing hormone testing in assessment of hypothalamic-pituitary-adrenal axis function in infants with congenital central hypothyroidism.
    van Tijn DA; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3794-803. PubMed ID: 18647808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity.
    Kalin NH; Shelton SE; Barksdale CM; Brownfield MS
    Brain Res; 1987 Nov; 426(2):385-91. PubMed ID: 2825918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.